Pravastatin Sodium tonogestrel CCT251545 alters WNT pathway-regulated gene

CCT251545 alters WNT pathway-regulated gene expression and other on-target effects of modulating CDK8 and CDK19

IC50 value: Target: calcium channel blockerin vitro: Efonidipine and nifedipine

(2001) J Neurochem

Formula: C7H16ClNO2

Pravastatin Sodium tonogestrel CCT251545 alters WNT pathway-regulated genePravastatin Sodium is an antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase Pravastatin competitively inhibits hepatic hydroxymethyl glutaryl coenzyme A reductase, the enzyme which catalyzes the conversion of HMG CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by